135 related articles for article (PubMed ID: 7695274)
1. New in vitro assay based on glucose consumption for determining intraconazole and amphotericin B activities against Aspergillus fumigatus.
Garrigues JC; Cadet de Fontenay G; Linas MD; Lagente M; Seguela JP
Antimicrob Agents Chemother; 1994 Dec; 38(12):2857-62. PubMed ID: 7695274
[TBL] [Abstract][Full Text] [Related]
2. Does hydrocortisone modify the in vitro susceptibility of Aspergillus fumigatus to itraconazole and amphotericin B?
Ramondenc I; Pinel C; Ambroise-Thomas P; Grillot R
Med Mycol; 1998 Apr; 36(2):69-73. PubMed ID: 9776816
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of fungal isolates of clinically important specimens to itraconazole, fluconazole and amphotericin B.
Dermoumi H
Chemotherapy; 1994; 40(2):92-8. PubMed ID: 8131639
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Guinea J; Peláez T; Alcalá L; Bouza E
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):273-6. PubMed ID: 17141455
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
Verweij PE; Mensink M; Rijs AJ; Donnelly JP; Meis JF; Denning DW
J Antimicrob Chemother; 1998 Sep; 42(3):389-92. PubMed ID: 9786480
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
Cuenca-Estrella M; Rodríguez-Tudela JL; Mellado E; Martínez-Suárez JV; Monzón A
J Antimicrob Chemother; 1998 Oct; 42(4):531-3. PubMed ID: 9818755
[TBL] [Abstract][Full Text] [Related]
7. Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus.
Shekhova E; Kniemeyer O; Brakhage AA
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848005
[TBL] [Abstract][Full Text] [Related]
8. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Guinea J; Peláez T; Alcalá L; Bouza E
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):53-5. PubMed ID: 16650953
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy.
Kontoyiannis DP; Lewis RE; Sagar N; May G; Prince RA; Rolston KV
Antimicrob Agents Chemother; 2000 Oct; 44(10):2915-8. PubMed ID: 10991890
[TBL] [Abstract][Full Text] [Related]
11. Modification of rapid susceptibility assay for antifungal susceptibility testing of Aspergillus fumigatus.
Wetter TJ; Hazen KC; Cutler JE
J Clin Microbiol; 2003 Sep; 41(9):4252-8. PubMed ID: 12958253
[TBL] [Abstract][Full Text] [Related]
12. Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.
Wetter TJ; Hazen KC; Cutler JE
Med Mycol; 2005 Sep; 43(6):525-32. PubMed ID: 16323310
[TBL] [Abstract][Full Text] [Related]
13. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of amphotericin B, clotrimazole and itraconazole against Aspergillus spp. An in vitro study.
Hahn YH; Ahearn DG; Wilson LA
Mycopathologia; 1993 Sep; 123(3):135-40. PubMed ID: 8302362
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.
Dannaoui E; Meletiadis J; Tortorano AM; Symoens F; Nolard N; Viviani MA; Piens MA; Lebeau B; Verweij PE; Grillot R; And The Ebga Network
J Med Microbiol; 2004 Feb; 53(Pt 2):129-134. PubMed ID: 14729934
[TBL] [Abstract][Full Text] [Related]
16. Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro.
Heller I; Leitner S; Dierich MP; Lass-Flörl C
Int J Antimicrob Agents; 2004 Oct; 24(4):401-4. PubMed ID: 15380269
[TBL] [Abstract][Full Text] [Related]
17. In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus.
Dannaoui E; Borel E; Persat F; Monier MF; Piens MA; Network E
J Med Microbiol; 1999 Dec; 48(12):1087-1093. PubMed ID: 10591162
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole.
Ramani R; Gangwar M; Chaturvedi V
Antimicrob Agents Chemother; 2003 Nov; 47(11):3627-9. PubMed ID: 14576132
[TBL] [Abstract][Full Text] [Related]
19. The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions.
Meletiadis J; te Dorsthorst DT; Verweij PE
Int J Antimicrob Agents; 2006 Nov; 28(5):439-49. PubMed ID: 17055706
[TBL] [Abstract][Full Text] [Related]
20. In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of sensititre versus NCCLS M38-A using two different inocula.
Drago M; Scaltrito MM; Cariani L; Morace G
J Chemother; 2004 Oct; 16(5):474-8. PubMed ID: 15565915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]